Akouos
Acquired
Healthy hearing available to all
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- akouos.com
- Total Funding
- $162.5M
- Last Round
- $105.0M Series BMar 2020
About
Akouos is a precision genetic medicine company developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people with disabling hearing loss. Focused on inner ear delivery and AAV gene therapy platforms, it was acquired by Eli Lilly. Targets genetic forms of hearing loss affecting 466 million worldwide.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account